Furthermore, when all SNPs within the ADRA1 receptor genes (ADRA1A, ADRA1B, ADRA1D) were removed from the model, the ADRA1 pathway remained associated with hypertension and DBP, suggesting that the observed pathway association was driven by genetic variants in several genes. This evidence concerns the gene DBP and hypertensive disorder.